The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial
Titel:
The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial
Auteur:
Dubsky, Peter C. Singer, Christian F. Egle, Daniel Wette, Viktor Petru, Edgar Balic, Marija Pichler, Angelika Greil, Richard Petzer, Andreas L. Bago-Horvath, Zsuzsanna Fesl, Christian Meek, Stephanie M. Kronenwett, Ralf Rudas, Margaretha Gnant, Michael Filipits, Martin